个体化的综合治疗开创了视网膜母细胞瘤(RB)临床诊治的新纪元,国内数家眼科中心为此进行了有益的尝试,但从总体上对这一疾病的认识尚有待提高。本文就推广RB的国际分期、改变对RB认识上的误区、提高RB的早期诊断率、加强多中心协作,提高国内RB临床研究的质量、开展RB临床基础研究等五个方面做一简要述评。 Individualized comprehensive treatment has opened up a new era of clinical diagnosis and treatment of retinoblastoma (RB). Several domestic ophthalmology centers have made useful attempts to this end, but the overall understanding of the disease needs to be improved. This article makes a brief comment on promoting the international staging of RB, changing the misunderstanding on RB, improving the early diagnosis rate of RB, strengthening the multi-center collaboration, improving the quality of domestic RB clinical research and carrying out RB clinical basic research.